Skip to main content
INmune Bio Inc. (INMB)
NASDAQ: INMB · Real-Time Price · USD
1.400
-0.070 (-4.76%)
At close: Apr 28, 2026, 4:00 PM EDT
1.395
-0.005 (-0.37%)
Pre-market: Apr 29, 2026, 7:49 AM EDT

INmune Bio Revenue

In the year 2025, INmune Bio had annual revenue of $50.00K with 257.14% growth.

Revenue (ttm)
$50.00K
Revenue Growth
+257.14%
P/S Ratio
744.39
Revenue / Employee
$2,381
Employees
21
Market Cap
37.22M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202550.00K36.00K257.14%
Dec 31, 202414.00K-141.00K-90.97%
Dec 31, 2023155.00K-219.00K-58.56%
Dec 31, 2022374.00K193.00K106.63%
Dec 31, 2021181.00K170.00K1,545.45%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Veru Inc. 16.89M
Palatin Technologies 8.96M
CervoMed 4.01M
Aligos Therapeutics 2.19M
Werewolf Therapeutics 1.14M
RenovoRx 1.12M
Actinium Pharmaceuticals 90.00K
Senti Biosciences 22.00K
Revenue Rankings

INMB News

More News